ESMO Gynae 2025 | Differential outcomes in elderly patients with early ovarian cancer

Felix Hilpert • 27 Jun 2025

ESMO Gynae 2025

Felix Hilpert, MD, Krankenhaus Jerusalem, Hamburg, Germany, comments on the poor prognosis of elderly patients with early ovarian cancer, highlighting that despite being able to treat the disease sufficiently, nearly a third of patients experience recurrent disease within the first two years after diagnosis, and nearly a quarter of patients die within the same period. This is in stark contrast to younger patients, who typically have a better prognosis. This interview took place at 2025 European Society for Medical Oncology (ESMO) Gynaecological Cancers Congress in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.